Linkage disequilibrium: ancient history drives the new genetics.

Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Human Heredity (Impact Factor: 1.64). 02/2005; 59(2):118-24. DOI: 10.1159/000085226
Source: PubMed

ABSTRACT This brief review provides a summary of the biological causes of genetic association between tightly linked markers--termed linkage disequilibrium--and unlinked markers--termed population structure. We also review the utility of linkage disequilibrium data in gene mapping in isolated populations, in the estimation of recombination rates and in studying the history of particular alleles, including the detection of natural selection. We discuss current understanding of the extent and patterns of linkage disequilibrium in the genome, and its promise for genetic association studies in complex disease. Finally, we highlight the importance of using appropriate statistical procedures, such as the false discovery rate, to maximize the chances of success in large scale association studies.

Download full-text


Available from: Thomas Nichols, Jun 19, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Association studies have emerged as a powerful tool for identification of markers associated with quantitative traits in forest trees. The cytosolic enzyme uridine 5′ diphosphate-glucose dehydrogenase (UGDH) converts UDP-glucose to UDP-glucuronate and affects cell wall formation in higher plants. Here, we used association genetics to identify UDP-glucose dehydrogenase (PtUGDH) allelic variation that associates with wood quality traits in Populus tomentosa. We isolated a 1,828 bp PtUGDH cDNA encoding a polypeptide of 481 amino acids. Expression analysis revealed that PtUGDH was expressed predominantly in young root, developing xylem from vascular tissues, and young leaves, suggesting that UGDH functions in cell wall formation. We identified 59 single-nucleotide polymorphisms (SNPs; π T = 0.00475) by resequencing the PtUGDH locus of 40 individuals and genotyped the 22 most common SNPs (minor allele frequency >10 %) in a discovery population (n = 426). Linkage disequilibrium (LD) analysis showed that LD did not extend over the entire gene (r 2 < 0.1, within 300 bp). Association studies indicated that three SNPs (false discovery rate, Q < 0.05) and 12 haplotypes (Q < 0.05) were significantly associated with wood properties. The three significant SNPs are all in the 5′ untranslated regions of PtUGDH, and the phenotypic variance explained by each SNP ranged from 5.37 to 11.97 %. We validated one association in a validation population (n = 1,200) and validated another association by examining its effect on gene expression. The present study provided molecular markers associated with fiber length and holocellulose content, markers that have potential applications in marker-assisted breeding.
    Tree Genetics & Genomes 04/2014; 10(2). DOI:10.1007/s11295-013-0689-6 · 2.44 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cognitive ability has a substantial genetic component and more than 15 candidate genes have been identified over the past 8years. One gene that has been associated with general cognitive ability is the cholinergic muscarinic 2 receptor (CHRM2). In an attempt to replicate this finding we typed marker rs8191992 (the originally reported CHRM2 SNP) in two population based cohorts—one Scottish aged over 50years (N=2,091) and the other English comprising non-demented elderly participants (N=758)—and a family-based Australian adolescent sample (N=1,537). An additional 29 SNPs in CHRM2 were typed in the Australian sample and a further seven in the English cohort. No significant association was found between CHRM2 and diverse measures of cognitive ability in any of the samples. In conclusion, this study does not support a role for CHRM2 in cognitive ability.
    Behavior Genetics 09/2009; 39(5):513-523. DOI:10.1007/s10519-009-9274-z · 2.84 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: With the development of new technologies for assaying biological activity on a global basis in experimental samples, various new "-omics" signatures have been developed to predict disease progression. Such signatures hold the potential to alter the nature of clinical management of human disease. In this article, we describe some necessary statistical considerations needed to take these signatures from the discovery phase to a clinically useful assay. Much of the work discussed is in the area of cancer.
    Genomics 09/2008; 93(1):13-6. DOI:10.1016/j.ygeno.2008.07.006 · 2.79 Impact Factor